4//SEC Filing
Corvus Pharmaceuticals, Inc. 4
Accession 0000899243-16-022400
$CRVSCIK 0001626971operating
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:06 PM ET
Size
5.7 KB
Accession
0000899243-16-022400
Insider Transaction Report
Form 4
Coloma Jason V
SVP, Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-06-08+200,000→ 200,000 totalExercise: $13.34Exp: 2026-06-08→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to twenty-five percent (25%) of the shares subject to the option on June 8, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001626971
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:06 PM ET
- Size
- 5.7 KB